Amarin's 15-minute chart triggered KDJ Golden Cross, bullish Marubozu trend.

Amarin's 15-minute chart has recently triggered a KDJ Golden Cross, accompanied by a bullish Marubozu at 09/05/2025 15:15. This development indicates a shift in the momentum of the stock price towards the upside, suggesting that it may continue to rise. As buyers maintain control of the market, it is likely that the bullish momentum will persist.

Amarin Corporation (AMRN) has seen a notable shift in its stock price momentum, with recent technical indicators suggesting a strong bullish trend. The 15-minute chart of Amarin's stock triggered a KDJ Golden Cross on September 02, 2025, at 15:15, accompanied by a bullish Marubozu candle. This development indicates a significant change in the stock's price dynamics, signaling potential upward movement.

The KDJ Golden Cross is a classic bullish signal that occurs when the K-line crosses above the D-line on the KDJ indicator. This crossover suggests that the stock is likely to continue its upward trend. Additionally, the presence of a bullish Marubozu candle further strengthens the bullish case, as it indicates strong buying pressure and a potential continuation of the upward momentum.

Analysts and traders have been closely monitoring Amarin's stock due to its potential for significant price appreciation. The company's focus on developing therapeutics for cardiovascular health, particularly its product Vascepa, has drawn considerable attention. Vascepa is a medication that has shown promising results in reducing triglyceride levels and may soon receive FDA approval for broader use in reducing cardiovascular events.

The stock's recent price action has been supported by strong fundamentals and technical indicators. Amarin has seen a significant increase in its short interest, with nearly 32% of the outstanding shares currently shorted. This high short interest could potentially lead to a short squeeze, driving the stock price higher as short sellers cover their positions.

In addition to the technical indicators, Amarin's fundamentals also support a bullish outlook. The company has a strong product pipeline and a solid track record of success in the biopharmaceutical industry. Its focus on lipid science and the potential therapeutic benefits of polyunsaturated fatty acids positions it well to capitalize on the growing demand for cardiovascular health solutions.

As investors and financial professionals, it is essential to stay informed about the latest developments in the market. Amarin Corporation's recent technical indicators suggest a strong bullish trend, and the company's fundamentals provide a solid foundation for continued growth. While the stock's price may be volatile in the short term, the long-term prospects appear promising.

References:
[1] https://www.tradingview.com/symbols/LSX-A41557/ideas/page-2/
[2] https://crypto.news/pump-price-eyes-29-rally-backed-by-token-buybacks-and-fresh-demand/